National Guideline Clearinghouse | Neoadjuvant or adjuvant therapy for resectable gastric cancer.
Program in Evidence-based Care || Cancer Care Ontario
December 2, 2013
Guideline Title
Neoadjuvant or adjuvant therapy for resectable gastric cancer.
Bibliographic Source(s)
| Knight G, Earle CC, Cosby R, Coburn N, Youssef Y, Spithoff K, Malthaner R, Wong RKS, Gastrointestinal Cancer Disease Site Group. Neoadjuvant or adjuvant therapy for resectable gastric cancer. Toronto (ON): Cancer Care Ontario (CCO); 2011 Apr 5. Various p. (Evidence-based series; no. 2-14). [147 references] |
Guideline Status
This is the current release of the guideline.
This guideline updates a previous version: Gastrointestinal Cancer Disease Site Group. Earle CC, Maroun J, Zuraw L. Neoadjuvant or adjuvant therapy for resectable gastric cancer [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2003 May 21 [online update]. 21 p. (Practice guideline; no. 2-14).
The EVIDENCE-BASED SERIES report, initially the full original Guideline, over time will expand to contain new information emerging from reviewing and updating activities.
Please visit the Cancer Care Ontario Web site
for details on any new evidence that has emerged and implications to the guidelines.
This guideline updates a previous version: Gastrointestinal Cancer Disease Site Group. Earle CC, Maroun J, Zuraw L. Neoadjuvant or adjuvant therapy for resectable gastric cancer [full report]. Toronto (ON): Cancer Care Ontario (CCO); 2003 May 21 [online update]. 21 p. (Practice guideline; no. 2-14).
The EVIDENCE-BASED SERIES report, initially the full original Guideline, over time will expand to contain new information emerging from reviewing and updating activities.
Please visit the Cancer Care Ontario Web site
for details on any new evidence that has emerged and implications to the guidelines.
.png)
No hay comentarios:
Publicar un comentario